Integrative multi-omics analysis of the CALM3-FRMD6-AS2 regulatory axis in gastric cancer reveals single-cell heterogeneity and enables construction of a prognostic model

Abstract Gastric cancer exhibits high tumour heterogeneity, which hinders precision treatment. Beyond canonical calcium-signalling roles, CALM3 acts as an RNA-binding-protein, while the lncRNA FRMD6-AS2 remains poorly characterised in gastric-cancer tumour microenvironment, especially in cancer-associated fibroblasts (CAFs). This study integrated TCGA-STAD bulk transcriptome and GSE183904 single-cell datasets to characterise the CALM3-FRMD6-AS2 regulatory axis. Multiple bioinformatic algorithms predicted their potential physical interaction. Single-cell analysis identified FRMD6-AS2 as an extremely rare CAF-specific lncRNA expressed n only 0.034 % of total cells. In silico perturbation demonstrated that FRMD6-AS2 knockdown disturbed the ZEB1-CDH1 epithelial axis and activated mesenchymal programmes, and CALM3 gradient rescue could not reverse epithelial damage, indicating their parallel-synergistic non-redundant regulation of EMT. qPCR, CCK-8, flow cytometry and scratch-wound-healing assays in HGC-27 cells validated that FRMD6-AS2 knockdown suppressed proliferation, promoted apoptosis and enhanced migration, whereas CALM3 over-expression exerted opposite cellular phenotypes. A LASSO-Cox-derived prognostic risk model incorporating CALM3-FRMD6-AS2 and clinical factors showed favourable predictive performance and consistent risk trends across external GEO cohorts. Bulk-omics negative results supported the signal-dilution effect caused by this rare CAF sub-population. In conclusion, the CALM3-FRMD6-AS2 axis marks a rare malignant CAF subset and cooperatively drives EMT-related malignant progression in gastric cancer, offering novel insights for CAF heterogeneity research and stroma-targeted therapeutic strategies.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-17
DOI
https://doi.org/10.21203/rs.3.rs-11358791/v1
Primary Topic
Cancer-related molecular mechanisms research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Integrative multi-omics analysis of the CALM3-FRMD6-AS2 regulatory axis in gastric cancer reveals single-cell heterogeneity and enables construction of a prognostic model

Fan Luo, Luyao Cheng, Xuelian Shu, Jing Li et al.
2 links
Research Square
Cancer-related molecular mechanisms research
preprint

Integrative multi-omics analysis of the CALM3-FRMD6-AS2 regulatory axis in gastric cancer reveals single-cell heterogeneity and enables construction of a prognostic model

Fan Luo, Luyao Cheng, Xuelian Shu, Jing Li, Yilin Wang, Ren Man
preprint en

Abstract

Abstract Gastric cancer exhibits high tumour heterogeneity, which hinders precision treatment. Beyond canonical calcium-signalling roles, CALM3 acts as an RNA-binding-protein, while the lncRNA FRMD6-AS2 remains poorly characterised in gastric-cancer tumour microenvironment, especially in cancer-associated fibroblasts (CAFs). This study integrated TCGA-STAD bulk transcriptome and GSE183904 single-cell datasets to characterise the CALM3-FRMD6-AS2 regulatory axis. Multiple bioinformatic algorithms predicted their potential physical interaction. Single-cell analysis identified FRMD6-AS2 as an extremely rare CAF-specific lncRNA expressed n only 0.034 % of total cells. In silico perturbation demonstrated that FRMD6-AS2 knockdown disturbed the ZEB1-CDH1 epithelial axis and activated mesenchymal programmes, and CALM3 gradient rescue could not reverse epithelial damage, indicating their parallel-synergistic non-redundant regulation of EMT. qPCR, CCK-8, flow cytometry and scratch-wound-healing assays in HGC-27 cells validated that FRMD6-AS2 knockdown suppressed proliferation, promoted apoptosis and enhanced migration, whereas CALM3 over-expression exerted opposite cellular phenotypes. A LASSO-Cox-derived prognostic risk model incorporating CALM3-FRMD6-AS2 and clinical factors showed favourable predictive performance and consistent risk trends across external GEO cohorts. Bulk-omics negative results supported the signal-dilution effect caused by this rare CAF sub-population. In conclusion, the CALM3-FRMD6-AS2 axis marks a rare malignant CAF subset and cooperatively drives EMT-related malignant progression in gastric cancer, offering novel insights for CAF heterogeneity research and stroma-targeted therapeutic strategies.

Research Square
First Hospital of Lanzhou University (CN), Lanzhou University (CN)
Good health and well-being
Cancer-related molecular mechanisms research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon